Evidence map›Paper›PMID 33754234›Full record

ArticlePediatric nephrology (Berlin, Germany)2021

Risk factors for kidney scarring and vesicoureteral reflux in 421 children after their first acute pyelonephritis, and appraisal of international guidelines.

Anders Breinbjerg, Cecilie Siggaard Jørgensen, Jørgen Frøkiær, Kjell Tullus, Konstantinos Kamperis, Søren Rittig

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Anders BreinbjergDepartment of Pediatric and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark. andbre@clin.au.dk.ORCID 0000-0002-8408-4381
Cecilie Siggaard JørgensenDepartment of Pediatric and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0003-3630-2329
Jørgen FrøkiærDepartment of Clinical Medicine, Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Aarhus University, Aarhus, Denmark.ORCID 0000-0002-6206-8065
Kjell TullusDepartment of Paediatric Nephrology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Konstantinos KamperisDepartment of Pediatric and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0003-0104-4884
Søren RittigDepartment of Pediatric and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0001-7038-1652
Aarhus University Hospital · DKGreat Ormond Street Hospital for Children NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute pyelonephritis (AP) is a common bacterial infection in childhood. Follow-up guidelines on these children are controversial. This study aimed to identify risk factors for kidney scarring and vesicoureteral reflux (VUR). Furthermore, international follow-up guidelines were used for simulation to evaluate sensitivity and specificity.

methodsUrinary culture-confirmed first-time AP patients (aged 0-14 years) were enrolled (n = 421) from review of patient charts. All underwent kidney ultrasound (US) and a technetium-99m-dimercaptosuccinic acid (DMSA) scan or technetium-99m-mercaptoacetyltriglycine scinti-renography (MAG3) at 4-6 months of follow-up. The international guidelines used for simulation were from the National Institute of Health UK (NICE), the American Association of Paediatrics (AAP) and the Swedish Paediatric Society (SPS).

results17.8% presented with an abnormal DMSA/MAG3 at follow-up, 7.1% were diagnosed with VUR grades III-V and 4.7% were admitted for surgery. Non-Escherichia coli infections, abnormal kidney US, elevated creatinine and delayed response to treatment (>48 h) were risk factors for abnormal DMSA findings and VUR grades III-V. NICE and SPS guidelines showed best sensitivity in diagnosing VUR grades III-V (75%) compared with AAP (56%).

conclusionsRisk factors are helpful in identifying the children in need of further investigations and minimizing invasive work-up for the rest. International guidelines on follow-up detect a varying number of children with kidney damage and/or significant VUR. Future work must focus on identifying more specific risk factors, better imaging, or specific biomarkers, to enhance sensitivity and specificity in detecting the children at high risk for developing recurrent infections and/or nephropathy.

Indexed as

GlomerulonephritisKidney DiseasesPyelonephritisVesico-Ureteral RefluxAcute DiseaseAdolescentChildChild, PreschoolHumansInfantInfant, NewbornKidneyRadiopharmaceuticalsRisk FactorsTechnetium Tc 99m Dimercaptosuccinic AcidUrinary Tract InfectionsRadiopharmaceuticalsTechnetium Tc 99m Dimercaptosuccinic AcidChildrenInfantsInternational guidelinesPreschoolRisk factorsUrinary tract infectionVUR

Identifiers

PMID33754234
OpenAlexW3137601808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.